Radical trachelectomy is an operation developed as an alternative to radical hysterectomy for patients with small-volume, early stage cervical cancer, who wish to retain their fertility. The body of the uterus is left in place, so that future pregnancies can occur. Patients who have undergone radical trachelectomy may face problems conceiving naturally and may request assisted conception. This article explains the operation and the difficulties that those working in reproductive medicine may face.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14647270600905342 | DOI Listing |
J Med Case Rep
November 2024
Tu Du Clinical Research Unit (TD-CRU), Tu Du Hospital, Ho Chi Minh City, Vietnam.
Background: Cervical cancer is the fourth most common malignant tumor in childbearing-age women. To date, cervical resection and fertility-sparing surgery are the trends in the era of minimally invasive management. However, a proper management remains crucial.
View Article and Find Full Text PDFArch Med Res
December 2024
Department of Obstetrics and Gynecology, Southern Illinois University, Springfield, Illinois, USA. Electronic address:
Cureus
October 2024
Obstetrics and Gynecology, Sapporo Medical University, Sapporo, JPN.
Vaginal trachelectomy, which involves resecting the cervix and its parametrium, is a fertility-sparing option for the treatment of early-stage cervical cancer. Although no consensus has been reached on whether simple or radical trachelectomy is preferable, the vaginal approach is typically avoided for tumors larger than 2 cm due to concerns about recurrence. However, some evidence suggests that fertility preservation may still be viable for select patients with larger tumors.
View Article and Find Full Text PDFInt J Gynecol Cancer
January 2025
Gynecology Oncology Department, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Eur J Surg Oncol
January 2025
Department of Maternal and Child Health, Obstetrics and Gynecology Clinic, Ospedale Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy; PhD School in Biomedical Sciences, Gender Medicine, Child and Women Health, University of Sassari, Sassari, Italy.
Objective: We assessed reproductive, obstetrical, and oncological outcomes in patients who underwent fertility-sparing treatment by including studies that adhere to the FIGO 2018 staging system.
Methods: Data on recurrence, mortality, pregnancy rate, live birth rate, and preterm delivery rate were collected.
Results: In patients with stages IA1, IA2, and IB1, the recurrence rate was 4.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!